1220
Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.
 patients with persistent elevated triglycerides: Subject; adding fenofibric acid to moderate-dose statin therapy: Treatment; persistent elevated triglycerides: Treatment.Disorder; fenofibric acid: Treatment.Drug; statin: Treatment.Drug; moderate-dose: Treatment.Dosage; fenofibric acid: Combination.Drug; statin: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 patients with persistent elevated triglycerides: Subject; adding fenofibric acid to moderate-dose statin therapy: Treatment; persistent elevated triglycerides: Treatment.Disorder; fenofibric acid: Treatment.Drug; statin: Treatment.Drug; moderate-dose: Treatment.Dosage; fenofibric acid: Combination.Drug; statin: Combination.Drug